SOPHiA GENETICS Joins CancerX to Help Accelerate Cancer Research
June 2, 2023
As a leader in data-driven medicine, SOPHiA GENETICS lends its expertise to support White House Cancer Moonshot BOSTON and LAUSANNE, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, announced today at ASCO that it has joined as a founding member of CancerX, a new public-private partnership [...]
June 2, 2023
Invivoscribe and Complete Genomics announced today that they had entered a partnership to develop and commercialize biomarker tests on Complete Genomics’ NGS platforms. The territory is worldwide, and the field is oncology and cancer research. Under the terms of the deal, Invivoscribe will be responsible for the development of biomarker tests, including test controls and [...]
Illumina’s Board of Directors elects two experienced Independent Directors to Board
June 2, 2023
Stephen P. MacMillan, Hologic CEO, named non-executive Chair of Illumina's Board Scott B. Ullem, CFO of Edwards Lifesciences, also named to Board SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a series of governance changes consistent with the goal of enhancing long-term shareholder value. The Board has [...]
June 2, 2023
As a leading innovator in the field of enzyme technology, Genovis today announces the launch of its cutting-edge IgM-specific protease. This highly efficient and specific enzyme holds significant potential within various life science sectors, including research, diagnostics and therapeutic applications. The newly developed IgM-specific protease demonstrates a remarkable level of effectiveness, exhibiting exceptional specificity towards [...]
June 2, 2023
– Cutting-edge spatial omics technologies to map cancer cells and their immune environment in high resolution, allowing AI to unlock potential for new breakthrough treatments – – Landmark research project is 100x larger than existing efforts – – Data will be generated from thousands of patients across multiple cancers – – University of Pittsburgh, Gustave Roussy, Lausanne University Hospital, [...]
Almaden Genomics Names Board of Advisors
June 2, 2023
DALLAS, TEXAS – Almaden Genomics has announced its Board of Advisors, a highly regarded group of healthcare leaders from both the public and private sectors with experience in cancer research, presicion medicine, biotechnology, clinical trials, bioinformatics, data visualization, computational analysis, pharmacology, and AI. The Board – which includes Adrian Lee, Ph.D., Samir Courdy; Rayna Herman; Graham [...]
June 1, 2023
We are thrilled to announce that world-renowned AFM expert Bart Hoogenboom will be joining Nanosurf as the new Head of Research and Development, starting in July. With an impressive academic background and significant experience building advanced scientific instruments, Bart is poised to make a significant impact on the future of our company. Bart is currently [...]
BIO-TECHNE SUCCESSFUL ON CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
June 1, 2023
MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it prevailed on a claim that Miltenyi Biotec B.V. & Co. KG commercialized antibodies it developed based on information obtained by reverse engineering Bio-Techne's proprietary R&D Systems branded TIGIT and CCR-7 antibodies. Specifically, the Court held "it has been proven that [Miltenyi's] TIGIT and CCR-7 antibodies are the [...]
AMETEK Announces Financial Executive Appointments
June 1, 2023
Berwyn, Pa. – AMETEK, Inc. (NYSE: AME) today announced that its Board of Directors has elected two new Vice Presidents. Frank Donnelly and John Hoffman III have been promoted to the positions of Vice President, Group Controller and Vice President, Audit Services, respectively, effective July 1, 2023. “I am pleased to announce the promotions of [...]
ZYMO RESEARCH LAUNCHES FULL-LENGTH 16S SEQUENCING SERVICE TO REVOLUTIONIZE MICROBIOME RESEARCH
June 1, 2023
IRVINE, Calif. — Zymo Research, a leading provider of microbiology research tools, has officially launched its Full-Length 16S Sequencing Service, offering researchers high-quality, full-length 16S rRNA gene sequencing for microbiome analysis. The new full-length 16S service provides researchers with greater species resolution and increased data quality while maintaining a cost-effective approach when compared to historic, short-read [...]
